[HTML][HTML] Safety and tolerability of metastasis-directed radiation therapy in the era of evolving systemic, immune, and targeted therapies
AbstractPurpose: Systemic, immune, and target therapies are growing in use in the
management of metastatic cancers. The aim of this review was to describe up-to-date …
management of metastatic cancers. The aim of this review was to describe up-to-date …
[HTML][HTML] Esophageal cancer in elderly patients, current treatment options and outcomes; a systematic review and pooled analysis
S Mantziari, H Teixeira Farinha, V Bouygues, JC Vignal… - Cancers, 2021 - mdpi.com
Simple Summary Any given treatment may provide improve survival for elderly patients with
oesophageal cancer compared to best supportive care. Although surgery may be related to …
oesophageal cancer compared to best supportive care. Although surgery may be related to …
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review
L Belgioia, I Desideri, A Errico, C Franzese… - Critical Reviews in …, 2019 - Elsevier
Purpose Aim of the present review is to assess present data about the use of the association
of Radiotherapy (RT) and targeted therapy/immunotherapy (TT/IT) in elderly people. Design …
of Radiotherapy (RT) and targeted therapy/immunotherapy (TT/IT) in elderly people. Design …
Advances in the pharmacotherapeutic management of esophageal squamous cell carcinoma
C Peng, DJ Cohen - Expert Opinion on Pharmacotherapy, 2021 - Taylor & Francis
Introduction Esophageal squamous cancer remains an important cause of mortality
worldwide with two new immunotherapy drugs recently approved for metastatic disease …
worldwide with two new immunotherapy drugs recently approved for metastatic disease …
[HTML][HTML] Long-term survival outcomes and comparison of different treatment modalities for stage I-III cervical esophageal carcinoma
Y Lu, C Xu, H Wang, T Song, S Wu, X Liang… - Frontiers in …, 2021 - frontiersin.org
Purpose: To investigate the survival outcomes, prognostic factors and treatment modalities
of stage I-III cervical esophageal carcinoma (CEC) patients using data from the Surveillance …
of stage I-III cervical esophageal carcinoma (CEC) patients using data from the Surveillance …
Safety of radiotherapy with concurrent docetaxel in older patients with esophageal cancer
T Kawamoto, N Shikama, M Oshima, Y Kosugi… - Journal of Geriatric …, 2020 - Elsevier
Objectives Considering that therapeutic strategies for older adult patients with esophageal
cancer (EC) remain controversial, we aimed to assess the safety of radiotherapy with …
cancer (EC) remain controversial, we aimed to assess the safety of radiotherapy with …
[HTML][HTML] Stage IIB-IVA cervix carcinoma in elderly patients treated with radiation therapy: a longitudinal cohort study by propensity score matching analysis
H Shou, Q Wan, H Xu, L Shi, T Song - BMC Women's Health, 2023 - Springer
Objective We aimed to evaluate the treatment modality and prognostic impact of the age at
diagnosis on stage IIB-IVA cervix carcinoma (CC) patients who received radiotherapy (RT) …
diagnosis on stage IIB-IVA cervix carcinoma (CC) patients who received radiotherapy (RT) …
[HTML][HTML] Survival Comparison Between Squamous Cell Carcinoma and Adenocarcinoma for Radiotherapy-Treated Patients with Stage IIB-IVA Cervical Cancer
F Chen, L Chen, Y Zhang, L Shi, H Xu, T Song - Frontiers in Oncology, 2022 - frontiersin.org
Objective: To compare the prognostic significance of adenocarcinoma (AC) with squamous
cell carcinoma (SCC) on overall survival (OS) in patients with stage IIB-IVA cervical cancer …
cell carcinoma (SCC) on overall survival (OS) in patients with stage IIB-IVA cervical cancer …
Radiotherapy in the management of lung oligometastases
V Bourbonne, A Lévy, J Khalifa, D Antoni, E Blais… - Cancer …, 2024 - Elsevier
In recent years, the development of both medical imaging and new systemic agents
(targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to …
(targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to …
[HTML][HTML] Case report: Efficacy of icotinib treatment in lung adenocarcinoma with esophageal squamous cell carcinoma: a rare case of double primary malignant tumors
M Deng, X Li, H Mu, M Wei, L Sun - Frontiers in Medicine, 2024 - frontiersin.org
Background Lung adenocarcinoma with esophageal squamous cell carcinoma is rare and
the prognosis is poor, therefore there is an urgent need to improve this situation. The …
the prognosis is poor, therefore there is an urgent need to improve this situation. The …